TrialAnnals of the rheumatic diseases2008

Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab.

S Visvanathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.